X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8) 8
index medicus (8) 8
rheumatology (8) 8
female (6) 6
male (6) 6
middle aged (6) 6
antirheumatic agents - adverse effects (5) 5
arthritis (5) 5
drug therapy (5) 5
rheumatoid arthritis (5) 5
american-college (4) 4
antibodies, monoclonal - adverse effects (4) 4
antirheumatic agents - therapeutic use (4) 4
arthritis, rheumatoid - drug therapy (4) 4
care and treatment (4) 4
disease-activity (4) 4
double-blind method (4) 4
methotrexate (4) 4
research (4) 4
tumor necrosis factor-tnf (4) 4
abridged index medicus (3) 3
antibodies, monoclonal - therapeutic use (3) 3
antirheumatic agents - administration & dosage (3) 3
dose-response relationship, drug (3) 3
drug dosages (3) 3
internal medicine (3) 3
magnetic resonance imaging (3) 3
monoclonal antibodies (3) 3
pharmaceutical industry (3) 3
rheumatoid factor (3) 3
safety (3) 3
severity of illness index (3) 3
studies (3) 3
treatment outcome (3) 3
validation (3) 3
adult (2) 2
analysis (2) 2
antibodies, monoclonal - administration & dosage (2) 2
arthritis, rheumatoid - pathology (2) 2
bone-marrow edema (2) 2
clinical trials (2) 2
clinical-trials (2) 2
combination (2) 2
computed-tomography (2) 2
definition (2) 2
diagnostic imaging (2) 2
drug administration schedule (2) 2
drug therapy, combination (2) 2
efficacy (2) 2
etanercept (2) 2
immunoglobulin g - therapeutic use (2) 2
inflammatory diseases (2) 2
infliximab (2) 2
lymphoma (2) 2
medical colleges (2) 2
medicine, general & internal (2) 2
methotrexate - therapeutic use (2) 2
receptors, tumor necrosis factor - therapeutic use (2) 2
rheumatic diseases - diagnosis (2) 2
rheumatism (2) 2
risk (2) 2
structural damage (2) 2
tnf inhibitors (2) 2
tumor necrosis factor (2) 2
tumor necrosis factor-alpha - antagonists & inhibitors (2) 2
1506 (1) 1
adalimumab (1) 1
adalimumab - administration & dosage (1) 1
adalimumab - adverse effects (1) 1
adalimumab - therapeutic use (1) 1
administration, oral (1) 1
agents (1) 1
analysis of variance (1) 1
ankylosing-spondylitis (1) 1
anti-tnf-alpha (1) 1
antibodies, monoclonal, humanized (1) 1
arthritis patients (1) 1
arthritis, psoriatic - drug therapy (1) 1
arthritis, rheumatoid - diagnosis (1) 1
arthritis, rheumatoid - diagnostic imaging (1) 1
articular-cartilage (1) 1
association (1) 1
biomarkers (1) 1
biomarkers - blood (1) 1
biotechnology industry (1) 1
cancer (1) 1
cartilage, articular - pathology (1) 1
cells (1) 1
chicago (1) 1
clinical and epidemiological research (1) 1
clinical outcomes (1) 1
clinical remission (1) 1
clinical trials as topic (1) 1
combination therapy (1) 1
conferences and conventions (1) 1
congresses as topic (1) 1
cytokines (1) 1
diagnostic imaging - methods (1) 1
diagnostic imaging - trends (1) 1
disease (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 390, Issue 10093, pp. 457 - 468
Summary Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. The Oral Rheumatoid Arthritis triaL (ORAL) Strategy... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | MODIFYING ANTIRHEUMATIC DRUGS | NECROSIS-FACTOR | PLACEBO | JANUS KINASE INHIBITOR | INADEQUATE RESPONSE | LONG-TERM SAFETY | PLUS METHOTREXATE | AMERICAN-COLLEGE | OPEN-LABEL | COMBINATION | Antirheumatic Agents - administration & dosage | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Adalimumab - adverse effects | Arthritis, Rheumatoid - drug therapy | Pyrroles - administration & dosage | Antirheumatic Agents - adverse effects | Pyrroles - adverse effects | Adult | Female | Drug Therapy, Combination | Pyrroles - therapeutic use | Antirheumatic Agents - therapeutic use | Severity of Illness Index | Piperidines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Pyrimidines - administration & dosage | Treatment Outcome | Methotrexate - adverse effects | Adalimumab - therapeutic use | Adalimumab - administration & dosage | Piperidines - therapeutic use | Pyrimidines - therapeutic use | Piperidines - adverse effects | Pyrimidines - adverse effects | Methotrexate - administration & dosage | Rheumatoid factor | Care and treatment | Analysis | Clinical trials | Arthritis | Pharmaceutical industry | Methotrexate | Rheumatology | Patients | Studies | Rheumatoid arthritis | Monoclonal antibodies | Rheumatism | TNF inhibitors | Janus kinase | Tumor necrosis factor-TNF | Safety | Drug therapy | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 386, Issue 9999, pp. 1137 - 1146
Journal Article
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 07/2007, Volume 66, Issue 7, pp. 893 - 899
Journal Article
The Lancet, ISSN 0140-6736, 07/2009, Volume 374, Issue 9685, p. 210
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/S0140-6736(09)60506-7 Byline: Josef S Smolen (a), Jonathan Kay (b),... 
Drug therapy | Rheumatoid arthritis | Research | Studies | Immunization | Monoclonal antibodies | Inflammatory diseases | Clinical outcomes
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.